MS

Mamta Sinha

Active Director Director DIN 06843199
DIN 06843199 First appointment Jul 2014 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2014
Shareholding value •••• Premium profile

About Mamta Sinha

Data last updated:

Mamta Sinha is a Director at Beopt Biotech Private Limited (since 2014). The company operates in Healthcare. Beopt Biotech Private Limited reported revenue of ₹64.6 Lakh (FY 2025).

DIN 06843199
Primary Designation Director
Industry Healthcare
First Appointment 25 Jul 2014
Oldest Company Age 12 yrs
Largest company Beopt Biotech Private Limited · ₹64.6 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Beopt Biotech Private Limited U74900BR2014PTC022623
Director25 Jul 20142014₹64.6 Lakh (FY 2025)Active

Board colleagues of Mamta Sinha

Directorship timeline

Open interactive timeline →
Beopt Biotech Private Limited
Premium access

Shareholding and investment profile for Mamta Sinha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mamta Sinha

Mamta Sinha currently holds 1 directorship: Beopt Biotech Private Limited (Director, since 25 Jul 2014, revenue ₹64.6 Lakh (FY 2025)).

Mamta Sinha was first appointed on 25 Jul 2014 as Director at Beopt Biotech Private Limited.

The current boards of Mamta Sinha's companies include Prakash Chandra Verma (Beopt Biotech Private Limited), Shiwani Anil Thakur (Beopt Biotech Private Limited), Umesh Kumar (Beopt Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available